One of the challenges you face when struggling with opioid dependence is how to deal with cravings. Cravings can interfere with your thinking and, at times, make using drugs seem unavoidable. Becoming more aware of the challenges and ways to deal with them can help you make better decisions day by day—including decisions that can help you stick with your SUBOXONE Film treatment plan and help you stay on track.
Start by taking a deep breath, and thinking about what's best for you
One giant step down the path of positive decision-making is being able to recognize the difference between these two questions:
| 1. | What do I want to do in this situation? |
|
| 2. | What's best for me in this situation? |
It isn't always easy to see the difference between the right and wrong decision in the heat of the moment, but you can learn to step back, count to ten, and take a moment to think about the important choices you're faced with.
| You should know: As with other opioids, buprenorphine can be abused. It's essential that your doctor monitor your use of SUBOXONE Film to help you achieve and maintain stability. You should also expect to make regular follow-up visits, especially if your doctor prescribes multiple refills. |
Remember to take better care of yourself:
 | Be your own best friend. |
|
| It's all right to take care of yourself. In fact, it's absolutely necessary for anyone working to manage opioid dependence. It starts with maintaining a positive attitude and making sure to relieve your stress. Taking better care of yourself is an important way of treating yourself with respect |
|
| Become a positive thinker. |
|
| Thinking more positively sounds easy, but old thought patterns can be difficult to break. A positive-thinking checklist can help you be more aware of your thoughts and help you learn how to overcome negative thoughts |
|
| Learn to live well. |
|
| Paying attention to your thoughts, feelings, behavior, relationships, and physical health can make a difference in how you feel about yourself and make the necessary changes in your life so you can make the decisions that will keep you on track |
As you learn to make better decisions and move closer to your treatment goals—we're here to help.
Take care,
866-973-HERE (4373)
Important Safety Information
SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII) is indicated for maintenance treatment of opioid dependence as part of a complete treatment plan to include counseling and psychosocial support. Treatment should be initiated under the direction of physicians qualified under the Drug Addiction Treatment Act.
SUBOXONE Sublingual Film should not be used by patients hypersensitive to buprenorphine or naloxone.
SUBOXONE Sublingual Film can be abused in a manner similar to other opioids, legal or illicit. Clinical monitoring appropriate to the patient's level of stability is essential.
Chronic use of buprenorphine can cause physical dependence. A sudden or rapid decrease in dose may result in an opioid withdrawal syndrome that is typically milder than seen with full agonists and may be delayed in onset.
SUBOXONE Sublingual Film can cause serious life-threatening respiratory depression and death, particularly when taken by the intravenous (IV) route in combination with benzodiazepines or other central nervous system (CNS) depressants (ie, sedatives, tranquilizers, or alcohol). It is extremely dangerous to self-administer nonprescribed benzodiazepines or other CNS depressants while taking SUBOXONE Sublingual Film. Dose reduction of CNS depressants, SUBOXONE Sublingual Film, or both when both are being taken should be considered.
Liver function should be monitored before and during treatment.
Death has been reported in nontolerant, nondependent individuals, especially in the presence of CNS depressants.
Children who take SUBOXONE Sublingual Film can have severe, possibly fatal, respiratory depression. Emergency medical care is critical. Keep SUBOXONE Sublingual Film out of the sight and reach of children.
Intravenous misuse or taking SUBOXONE Sublingual Film before the effects of full-agonist opioids (eg, heroin, hydrocodone, methadone, morphine, oxycodone) have subsided is highly likely to cause opioid withdrawal symptoms.
Neonatal withdrawal has been reported. Use of SUBOXONE Sublingual Film in pregnant women or during breast-feeding should only be considered if the potential benefit justifies the potential risk. Caution should be exercised when driving vehicles or operating hazardous machinery, especially during dose adjustment.
Adverse events commonly observed with the sublingual administration of SUBOXONE Sublingual Film are numb mouth, sore tongue, redness of the mouth, headache, nausea, vomiting, sweating, constipation, signs and symptoms of withdrawal, insomnia, pain, swelling of the limbs, disturbance of attention, palpitations, and blurred vision.
Cytolytic hepatitis, jaundice, and allergic reactions, including anaphylactic shock, have been reported.
This is not a complete list of potential adverse events associated with SUBOXONE Sublingual Film. Please see full Product Information for a complete list.
To report an adverse event associated with taking SUBOXONE Sublingual Film, please call 1-877-782-6966. You are encouraged to report adverse events of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please see full Product information and Medication Guide for Suboxone Film
For more about SUBOXONE Tablet, please see full Product Information
|
|
|
